Description
SKU | Health Concern | Pack Size | Main Ingredient | Specialty | Brand |
---|---|---|---|---|---|
3618 | Heart Support | 450 ml | Arjuna | 100% Natural | Baidyanath |
Baidyanath Arjunarishta
This herbal blend is an effective treatment of heart and circulatory conditions caused by constriction and blockage of the arteries, plaque build-up on vessel walls, and hypertension. Its primary ingredient Terminalia Arjuna was introduced into the ayurvedic catalogue in the 7th century for its effectiveness against these and other ailments. Recent chemical analysis has shown it to possess a unique combination of flavonoids and glycocides which have been detected to exert antioxidant, anti-inflammatory and lipid lowering effects while also being cardiotonic. While the remaining ingredients are used to alleviate pain and inflammation which is associated with the constriction of blood vessels, as is the case of haemorrhoids. They further aid in the rejuvenation of blood vessels which have been damaged by constriction, impact, or dryness, which are often complicating effects of hypertension or general injury.
Ingredients: Terminalia arjuna, Vitis vinifera, Woodfordia fruticosa, Madhuca indica.
Suggested Use: Take 4 spoonfuls twice daily.
Pack Size: 450ml
***************
About Baidyanath:
One of India’s most respected Companies, Shree Baidyanath Ayurved Bhawan (p) Ltd. (Kolkata), popularly known as Baidyanath, is the acknowledged leader of Ayurvedic know-how. Established in 1917, the Company has played a pioneering role in re-establishing ancient knowledge with modern research and manufacturing techniques.
AYURVEDA is a 5000 year old Science of health care and herbal treatment. AYURVEDA, is highly effective in common and complicated ailments, assures long term relief and has no side effects. AYURVEDA is now backed by modern scientific research and technologies and provides its gentle healing touch to millions around the world. *** Please note that this product is packaged in a Plastic Bottle***
Reviews
There are no reviews yet.